ATAT Earnings

ATAT reported its FY2025Q3 earnings on 2025-11-25, showcasing a revenue of 3.00B against an estimate of 2.00B, resulting in a 6.93% surprise. The EPS was 0.48, surpassing the expected 0.45 by 6.67% . The stock experienced a -1.77% price change on the earnings day and a 6.87% change over the next five days, reflecting market reactions to the results.

Following ATAT's FY2025Q3 earnings announcement on 2025-11-25, the stock price moved by -1.77% on the day of the release. Over the subsequent five days, it saw a 6.87% change. Historically, ATAT's stock price tends to shift by an average of -0.53% in the 10 days leading up to earnings and -2.00% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate ATAT’s annual revenue to reach 3.00B, while the EPS is projected at 3.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 2.94% and EPS estimates Revise Upward by 5.77% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between ATAT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 2.94%, while EPS estimates moved Revise Upward by 5.77% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ATAT's stock price typically moves by -0.53% in the 10 days before its earnings and -2.00% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 3.00 and revenue of 3.00B.

The earnings call highlights strong financial performance with a 28.7% increase in Adjusted EBITDA and a healthy cash position. The company is expanding its hotel network and retail business, with optimistic guidance of 35% revenue growth. Positive developments include increased dividends, a share repurchase program, and raised retail revenue guidance. Despite increased expenses, the strategic expansion and robust RevPAR trends suggest a positive outlook. The market cap indicates moderate sensitivity, aligning with a positive stock price movement prediction of 2% to 8% over the next two weeks.